Expanding the Huntington’s disease research toolbox; validated subdomain protein constructs for biochemical and structural investigation of huntingtin
暂无分享,去创建一个
E. Wanker | C. Arrowsmith | S. Lea | P. Loppnau | A. Hutchinson | J. Deme | R. Harding | M. Alqazzaz | A. Seitova | Christopher Secker | Renu Chandrasekaran | M. Alteen | E. S. Ramos | Claudia P. Alvarez
[1] H. Taguchi,et al. Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties. , 2022, ACS medicinal chemistry letters.
[2] E. Wanker,et al. Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. , 2022, Cell systems.
[3] A. Heck,et al. Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1 , 2021, Communications Biology.
[4] K. Lindenberg,et al. HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease , 2021, Neurobiology of Disease.
[5] W. Baumeister,et al. PolyQ expansion does not alter the Huntingtin-HAP40 complex , 2021, bioRxiv.
[6] Daphne Lelieveld,et al. Discovery of small molecules that induce lysosomal cell death incancer cells using a phenotypic screening platform , 2021 .
[7] Cyril F. Reboul,et al. SIMPLE 3.0. Stream single-particle cryo-EM analysis in real time. , 2020, Journal of structural biology.
[8] D. Marchionini,et al. HAP40 is a conserved central regulator of Huntingtin and a specific modulator of mutant Huntingtin toxicity , 2020, bioRxiv.
[9] Vicky L Brandt,et al. Traffic signaling: new functions of huntingtin and axonal transport in neurological disease , 2020, Current Opinion in Neurobiology.
[10] E. Wanker,et al. The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease , 2019, Journal of neurochemistry.
[11] Matthieu Schapira,et al. Targeted protein degradation: expanding the toolbox , 2019, Nature Reviews Drug Discovery.
[12] M. Li,et al. Reduced mitochondrial fusion and Huntingtin levels contribute to impaired dendritic maturation and behavioral deficits in Fmr1 mutant mice , 2019, Nature Neuroscience.
[13] C. Arrowsmith,et al. Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems , 2019, The Journal of Biological Chemistry.
[14] M. Rosenau. Data availability , 2018 .
[15] Sigrid Schnoegl,et al. LuTHy: a double‐readout bioluminescence‐based two‐hybrid technology for quantitative mapping of protein–protein interactions in mammalian cells , 2018, Molecular systems biology.
[16] N. Chen,et al. Blockade of the swelling-induced chloride current attenuates the mouse neonatal hypoxic-ischemic brain injury in vivo , 2018, Acta Pharmacologica Sinica.
[17] Y. Hashimoto,et al. Discovery of Small Molecules that Induce the Degradation of Huntingtin. , 2017, Angewandte Chemie.
[18] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[19] S. Humbert,et al. The Biology of Huntingtin , 2016, Neuron.
[20] H. Bellen,et al. Huntingtin Functions as a Scaffold for Selective Macroautophagy , 2015, Nature Cell Biology.
[21] R. Truant,et al. A huntingtin-mediated fast stress response halting endosomal trafficking is defective in Huntington's disease. , 2015, Human molecular genetics.
[22] M. Howarth,et al. Site-specific biotinylation of purified proteins using BirA. , 2015, Methods in molecular biology.
[23] David E. Housman,et al. Extensive changes in DNA methylation are associated with expression of mutant huntingtin , 2013, Proceedings of the National Academy of Sciences.
[24] M. Hayden,et al. A fully humanized transgenic mouse model of Huntington disease. , 2013, Human molecular genetics.
[25] R. Cole,et al. Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis , 2012, Cell cycle.
[26] J. Yates,et al. Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis* , 2012, The Journal of Biological Chemistry.
[27] R. Atwal,et al. Kinase inhibitors modulate huntingtin cell localization and toxicity. , 2011, Nature chemical biology.
[28] R. Roos,et al. Huntington's disease: a clinical review , 2010, Orphanet journal of rare diseases.
[29] John Mitchell,et al. Small Molecule Immunosensing Using Surface Plasmon Resonance , 2010, Sensors.
[30] M. MacDonald,et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models , 2009, Neurobiology of Disease.
[31] F. Niesen,et al. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability , 2007, Nature Protocols.
[32] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[33] R. Deshaies,et al. Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] P Bork,et al. Comparison of ARM and HEAT protein repeats. , 2001, Journal of molecular biology.
[35] C. Ross,et al. Isolation of a 40-kDa Huntingtin-associated Protein* , 2001, The Journal of Biological Chemistry.